Research: Vape Use to Exceed Traditional Tobacco

Market by 2FIRSTS.ai
Dec.26.2023
Research: Vape Use to Exceed Traditional Tobacco
E-cigarette usage predicted to surpass traditional tobacco in the coming years, with similar health risks identified.

According to a report by Turkish media outlet NTV on December 26th, research predicts that e-cigarette usage will surpass traditional tobacco in the coming years. A study presented at the annual conference of the American Heart Association revealed that frequent users of nicotine from e-cigarettes performed worse on a treadmill test used to measure the risk of heart disease compared to non-tobacco users, indicating similar harmful health effects to traditional tobacco.

 

New research conducted in a laboratory has revealed a potential association between e-cigarettes and certain types of cancer. According to data from Action on Smoking and Health, an organization against smoking and promoting health, nearly one in every 20 teenagers aged 11 to 15 in England regularly use e-cigarettes.

 

Experts are concerned that certain components of designed e-cigarettes are intended to entice teenagers by incorporating flavors such as blackberry, posing a potential risk of nicotine addiction for the younger generation.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Caixin Reports: Yiling’s Atomizer Sparks Public Concern as Experts Call for Stronger Oversight
Caixin Reports: Yiling’s Atomizer Sparks Public Concern as Experts Call for Stronger Oversight
Caixin reports that a Yiling Pharmaceutical subsidiary’s atomizer, resembling an e-cigarette, has sparked public concern. Experts classify herbal atomizers as e-cigarettes and call for stricter oversight. China’s tobacco regulator has confirmed such products fall under e-cigarette rules and pledged to maintain strict enforcement.
Jul.31
Ireland Health Survey: Youth Vaping on the Rise, 24% Usage Rate Among 18–34 Age Group
Ireland Health Survey: Youth Vaping on the Rise, 24% Usage Rate Among 18–34 Age Group
Ireland’s Central Statistics Office reports that 23.6% of people aged 18–34 use e-cigarettes, while traditional smoking is most prevalent among those aged 45–54 (13.3%). The survey also found only 50.8% of 18–24-year-olds rated their mental health as “very good,” with cannabis use reaching 22%, highlighting significant health risks among younger demographics.
Jul.14 by 2FIRSTS.ai
Altria Raises Dividend to $1.06; Annual Payout Ratio Rises to 78%
Altria Raises Dividend to $1.06; Annual Payout Ratio Rises to 78%
U.S. tobacco giant Altria Group, Inc. (NYSE: MO) announced a 3.9% increase to its quarterly dividend, lifting the payout to $1.06 per share and bringing the annualized dividend to $4.24. Investment bank Stifel on August 21 maintained its “Buy” rating and raised its price target from $65 to $72. Backed by strong free cash flow, Altria expects to maintain mid-single-digit dividend growth going forward.
Aug.29 by 2FIRSTS.ai
U.S. Fifth Circuit Court Rejects Shenzhen IVPS Appeal: Lack of Abuse Liability Research Key to Loss
U.S. Fifth Circuit Court Rejects Shenzhen IVPS Appeal: Lack of Abuse Liability Research Key to Loss
On July 23, 2025, the U.S. Court of Appeals for the Fifth Circuit ruled to reject the petition for judicial review filed by Shenzhen IVPS Technology Co., Ltd. (IVPS) and its U.S. distributor ECIGRUSA (Worldwide Vape Distribution) against the FDA, thereby upholding the FDA’s denial of their Premarket Tobacco Product Applications (PMTAs) for six open-system e-cigarette devices and components. The court held that the lack of key evidence on “abuse liability” alone was sufficient grounds to support
Aug.15 by 2FIRSTS.ai
2Firsts Exclusive with Former WHO Director Tikki Pang: FCTC Overlooks Tobacco Harm Reduction, and Asia’s Tobacco Control Challenges Demand Urgent Solutions
2Firsts Exclusive with Former WHO Director Tikki Pang: FCTC Overlooks Tobacco Harm Reduction, and Asia’s Tobacco Control Challenges Demand Urgent Solutions
Ahead of AFN25, 2Firsts interviewed former WHO director Tikki Pang, who reflected on two decades of the FCTC. While acknowledging its early successes, Pang pointed to its greatest shortcoming—excluding tobacco harm reduction—and noted its limited impact in Asia. He called for advancing THR and emphasized that proper regulation should balance reducing risks for adults and preventing youth access, while ensuring affordability and curbing illicit trade.
Aug.26
2Firsts Analysis: 69.8% of North American Cannabis Vapes Lack Clear Ingredient Labeling, Raising Compliance and Safety Concerns
2Firsts Analysis: 69.8% of North American Cannabis Vapes Lack Clear Ingredient Labeling, Raising Compliance and Safety Concerns
In August 2025, the Journal of Studies on Alcohol and Drugs published a study analyzing the packaging of Delta-8 THC products in North America. 2Firsts focused on the cannabis vape segment, which accounts for 37.9% of the sample, often with high concentrations—yet 69.8% lacked clear potency information, and only 11.7% carried health warnings on the main display panel.
Aug.15 by 2FIRSTS.ai